Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;43(1):1-6.
doi: 10.1097/DSS.0000000000000822.

Chlorhexidine Keratitis: Safety of Chlorhexidine as a Facial Antiseptic

Affiliations
Review

Chlorhexidine Keratitis: Safety of Chlorhexidine as a Facial Antiseptic

Kenneth D Steinsapir et al. Dermatol Surg. 2017 Jan.

Abstract

Background: Effective antiseptic to reduce surgical site infections is a cornerstone of modern surgery. Chlorhexidine gluconate-based antiseptics are among the most effective of these products. Unfortunately, chlorhexidine solutions are toxic to the cornea and middle ear, and they pose a splash risk to both the patient and health care personnel.

Objective: To examine the clinical evidence that led to the disavowal of chlorhexidine antiseptic solution for use on the face and head.

Methods and materials: Reference searches were performed using PubMed, Embase, and LexisNexis databases without restriction to the date of publication, language, or study setting.

Results: The literature revealed 11 sentinel cases of severe chlorhexidine-related keratitis in the late 1980s. These cases are reviewed together with data on ototoxicity and alternative products to understand why chlorhexidine solution should not be used on the face and scalp.

Conclusion: Chlorhexidine antiseptic solutions are highly effective. However, they pose a risk to the middle ear and have the potential to irreversibly damage the cornea with a minimal splash exposure. Povidone-iodine is a safe and effective alternative.

PubMed Disclaimer

Comment in

  • Commentary on Chlorhexidine Keratitis.
    Humphrey S. Humphrey S. Dermatol Surg. 2017 Jan;43(1):9-10. doi: 10.1097/DSS.0000000000000899. Dermatol Surg. 2017. PMID: 27870651 No abstract available.
  • Commentary on Chlorhexidine Keratitis.
    Biesman B. Biesman B. Dermatol Surg. 2017 Jan;43(1):7-8. doi: 10.1097/DSS.0000000000000978. Dermatol Surg. 2017. PMID: 28009679 No abstract available.
  • Comment on Chlorhexidine Keratitis.
    Steinsapir KD, Woodward J. Steinsapir KD, et al. Dermatol Surg. 2017 Sep;43(9):1180. doi: 10.1097/DSS.0000000000001172. Dermatol Surg. 2017. PMID: 28430730 No abstract available.
  • Commentary on Chlorhexidine Keratitis.
    Hsu SH, Weiss RA. Hsu SH, et al. Dermatol Surg. 2017 Sep;43(9):1180-1181. doi: 10.1097/DSS.0000000000001177. Dermatol Surg. 2017. PMID: 28746257 No abstract available.
  • Commentary on Chlorhexidine Keratitis.
    Steinsapir KD. Steinsapir KD. Dermatol Surg. 2019 May;45(5):749-750. doi: 10.1097/DSS.0000000000001621. Dermatol Surg. 2019. PMID: 30020098 No abstract available.

MeSH terms